Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Ponce
    Ponce
  4. Dahi
    Dahi
  5. Jakubowski
    Jakubowski
  6. Papadopoulos
    Papadopoulos
  7. Shah
    Shah
  8. Sauter
    Sauter
  9. Barker
    Barker
  10. Devlin
    Devlin

Groups

  1. CTCR Scholars (219)
  2. MSK Grad Students (219)
  3. Master of Science in Clinical and Translational Cancer Research (219)
  4. Department of Medicine (217)
  5. Hematologic Malignancies, Division of (209)
  6. Center for Hematologic Malignancies (208)
  7. Bone Marrow Transplant (207)
  8. Survivorship Research (166)
  9. Biostatistics Service (111)
  10. Epidemiology and Biostatistics (111)
Search Within
  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (140)
  2. Journal Article (66)
  3. Review (8)
  4. Editorial (2)
  5. Guidelines (2)
  6. Book Section (1)
Groups
  1. CTCR Scholars (219)
  2. MSK Grad Students (219)
  3. Master of Science in Clinical and Translational Cancer Research (219)
  4. Department of Medicine (217)
  5. Hematologic Malignancies, Division of (209)
  6. Center for Hematologic Malignancies (208)

More Groups

People
  1. Sergio Giralt (159)
  2. Miguel-Angel Perales (133)
  3. Doris Ponce (108)
  4. Parastoo Dahi (104)
  5. Sean Devlin (103)
  6. Roni Tamari (87)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (4)
  4. 2022 (28)
  5. 2021 (11)
  6. 2020 (30)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (153)
  2. Transplantation and Cellular Therapy (42)
  3. Clinical Lymphoma, Myeloma and Leukemia (6)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. European Journal of Cancer (3)
  6. Cancer Treatment Reviews (2)

More Publications

Results (219)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adding centralized electronic patient-reported outcome data collection to an established international clinical outcomes registry
    Journal Article

    Cusatis, R.; Flynn, K. E.; Vasu, S.; Pidala, J.; Muffly, L.; Uberti, J.; Tamari, R.; Mattila, D.; Mussetter, A.; Bruzauskas, R.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
    Journal Article

    Shah, N.; Dahi, P. B.; Ponce, D. M.; Sauter, C. S.; Shaffer, B. C.; Chung, D. J.; Politikos, I.; Lin, R. J.; Giralt, S. A.; Papanicolaou, G.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Real-time reflectance confocal microscopy of cutaneous graft-versus-host disease correlates with histopathology
    Journal Article

    Reingold, R. E.; Monnier, J.; ArdigoĢ€, M.; Stoll, J. R.; Pena, M. C.; Nanda, J. K.; Dusza, S. W.; Ruiz, J. D.; Flynn, L.; Afrin, A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Immune reconstitution following high-dose chemotherapy and autologous stem cell transplantation with or without pembrolizumab maintenance therapy in patients with lymphoma
    Journal Article

    Merryman, R. W.; Redd, R.; Jeter, E.; Wong, J. L.; McHugh, K.; Reynolds, C.; Nazzaro, M.; Varden, A.; Brown, J. R.; Crombie, J. L.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Employing competing risks analysis in an aging population where many patients die from other causes
    Journal Article

    Flynn, J. R.; Bartlett, E. K.; Lichtman, S. M.; Panageas, K. S.
    Journal of Geriatric Oncology (2022)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Sheth, A. H.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R. K.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in allograft recipients
    Journal Article

    Tamari, R.; Brown, S.; Devlin, S. M.; Kosuri, S.; Maloy, M. A.; Ponce, D. M.; Sauter, C.; Shaffer, B.; Dahi, P.; Young, J. W.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Five-year overall survival from the CheckMate 205 study of nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (cHL)
    Meeting Abstract

    Ansell, S.; BroĢˆckelmann, P.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G.; Cohen, J.; De Boer, J. P.; Kuruvilla, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save